Command Palette

Search for a command to run...

BALAXI

43.51+0.09%
Market Cap
₹239.99 Cr
Stock P/E
12.71
ROCE
13.01%
ROE
11.68%
Book Value
₹42.03

Financials

YoY Net Sales
EPS Growth
Operating Margin

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Institution
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Laggard

Balaxi Pharmaceuticals Ltd. shows significant weaknesses in growth, profitability, and valuation metrics compared to its peers. Its negative revenue growth and return metrics indicate financial distress, making it a sector laggard in the trading industry. In contrast, companies like Adani Enterprises and Redington are strong performers with solid growth and profitability.

Key Points
  • Balaxi Pharmaceuticals has the lowest revenue growth YoY and 3-Year among peers.
  • It also demonstrates negative ROE and ROA, indicating poor profitability.
  • Adani Enterprises leads in ROE and EPS growth, while Balaxi is the weakest in all financial aspects.
Top Performers
Adani Enterprises Ltd.

Leads in growth and profitability with strong EPS and ROE.

Redington Ltd.

Well-rounded performance with solid ROE and manageable debt levels.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.